Taiwan FDA registration ee1534eab647049a36e3393c1a6052dc
Relisul (including lidocaine)
TW: 瑞麗舒(含利多卡因)
Taiwan·Risk Class 3·Q-MED AB·Registered Oct 21, 2011 – Oct 21, 2026ActiveRegistration details
- Analysis ID
- ee1534eab647049a36e3393c1a6052dc
- Customs Code
- DHA00602299200
Company information
- Manufacturer
- Q-MED AB
- Manufacturer Country
- Sweden
- Authorized Representative
- GALDERMA HONG KONG LIMITED, TAIWAN BRANCH
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- I General, Plastic Surgery and Dermatology
- Import Information
- import
Dates and status
- Registration Date
- Oct 21, 2011
- Expiry Date
- Oct 21, 2026
About this record
Access comprehensive regulatory information for Relisul (including lidocaine) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number ee1534eab647049a36e3393c1a6052dc and manufactured by Q-MED AB. The authorized representative in Taiwan is GALDERMA HONG KONG LIMITED, TAIWAN BRANCH.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices